Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
Background: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of cisplatin-induced hearing loss. Objective: To find out if atorvastatin reduces hearing loss in people treated with cisplatin and radiation. Eligibility: People ages 18 and older with squamous cell carcinoma of the head and neck who will undergo treatment with cisplatin-based chemotherapy and ra
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Check if you qualify for this head and neck cancer clinical trial in Rochester, NY
If you're searching for head and neck cancer treatment options in Rochester, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.